Effectiveness of adalimumab in combination with intense pulsed light and radiofrequency therapy (LAight®) for severe hidradenitis suppurativa: A case report
| Autor: | Kerstin Steinbrink, Sophia Zimmer, Uwe Kirschner, Berenice M. Lang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment laight® therapy hidradenitis suppurativa Treatment options Intense pulsed light lcsh:RL1-803 medicine.disease Dermatology adalimumab medicine Adalimumab lcsh:Dermatology General Earth and Planetary Sciences Chronic skin disease Symptom control Hidradenitis suppurativa Stage (cooking) business Acne General Environmental Science medicine.drug |
| Zdroj: | Journal of Dermatology and Dermatologic Surgery, Vol 24, Iss 2, Pp 133-134 (2020) |
| ISSN: | 2352-2429 2352-2410 |
| Popis: | Hidradenitis suppurativa (HS also named as acne inversa) is a chronic skin disease characterized by relapsing formation of abscesses, inflammatory nodules, and fistulas. In moderate-to-severe disease, HS leads to the formation of scarring and thus irreversible tissue destruction. In the past few years, two new treatment options became available: adalimumab, the first biologic therapy approved for HS (Humira®, AbbVie), and a noninvasive, device-based treatment utilizing a combination of intense pulsed light and radiofrequency (LAight® therapy, LENICURA, Germany). Here, we report a case of a Hurley stage III patient where the positive effect of adalimumab could be enhanced by simultaneously applying LAight® therapy. Moreover, long-term symptom control could be achieved under monotherapy with LAight® after adalimumab was terminated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|